BENDAMUSTIN KABI

Powder for concentrate for solution for infusion, 25mg
RxActive license

Active substance (INN)

bendamustine

Pharmaceutical form

Pharmaceutical formPowder for concentrate for solution for infusion
Strength25mg
PackagingUkupno 1 bočica staklena sa praškom za koncentrat za rastvor za infuziju u kartonskoj kutiji
ManufacturerFresenius Kabi Deutschland GmbH, Germany
Therapeutic groupAntineoplastic and immunomodulating agents (L01AA09)
Marketing authorization holderAMICUS PHARMA DOO PODGORICA
Authorization dateNovember 4, 2025

Analogs in Montenegro

3

Other medicines with the same active substance

BENDAMUSTIN ALKALOIDRx
Powder for concentrate for solution for infusion, 100mgAlkaloid AD Skopje
BENDAMUSTIN ALKALOIDRx
Powder for concentrate for solution for infusion, 25mgAlkaloid AD Skopje
BENDAMUSTIN KABIRx
Powder for concentrate for solution for infusion, 100mgFresenius Kabi Deutschland GmbH
Source: CInMED register